Common genetic risk factors for coronary artery disease: new opportunities for prevention?
Atherosclerotic cardiovascular disease (CVD) is a leading cause of mortality and morbidity worldwide, with coronary artery disease (CAD) being the single leading cause of death. Better control of risk factors, enhanced diagnostic techniques and improved medical therapies have all substantially decreased the mortality of CAD in developed countries. However, CAD and other forms of atherosclerotic CVD are projected to remain the leading cause of death by 2030 and we face a number of challenges if the outcomes of CAD are to be further improved. The fact that a substantial fraction of high-risk subjects do not reach treatment goals for important risk factors is one of these challenges. At the same time, there is also a non-negotiable fraction of 'concealed' high-risk subjects who are not detected by current risk algorithms and diagnostic modalities. In recent years, we have started to rapidly increase our knowledge of the framework of common genetics underlying CAD and atherosclerotic CVD in the population. In conjunction with modern diagnostic and therapeutic options, this new genetic knowledge may provide a valuable tool for further improvements in prevention. This review summarizes the recent findings from the search for common genetic risk factors for CAD. Furthermore, the author discusses how such recent findings could potentially be used in a number of clinical applications within CAD prevention, including in clinical risk stratification, in prediction of drug treatment response and in the search for targets for novel preventive therapies.
Department of Clinical Sciences, Faculty of Medicine, Lund University, Malmö, Sweden.|Department of Medical Imaging and Physiology, Skåne University Hospital, Malmö, Sweden.
Viktor
V
Hamrefors
D003324:Coronary Artery Disease / Q000175:diagnosis / Q000235:genetics* / Q000517:prevention & control*; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D006801:Humans; D025202:Molecular Diagnostic Techniques; D010597:Pharmacogenetics / Q000379:methods; D000071184:Pharmacogenomic Variants; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide; D057285:Precision Medicine / Q000379:methods; D011237:Predictive Value of Tests; D011322:Primary Prevention; D012307:Risk Factors
D005819:Genetic Markers
atherosclerosis; cardiovascular disease genetics; cardiovascular risk factors; chromosome 9p21; coronary artery disease; modern diagnostics; single nucleotide polymorphism